Results 81 to 90 of about 41,937 (243)
Clinical Case Reports, Volume 13, Issue 10, October 2025.Recurrent chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) presenting with severe parathyroid hormone related peptide‐mediated hypercalcemia. Bone marrow and paravertebral biopsies confirmed relapse without evidence of Richter's transformation.
Srikar Tallavajhala +4 more
wiley +1 more source
Clinical and experimental thyroidology, 2011 Рак околощитовидных желез (РОЩЖ) – редкоезлокачественное заболевание. У больных РОЩЖ, как правило, отмечается тяжелое течение гиперпаратиреоза с высокими показателями кальция и паратгормона (ПТГ) в крови. Кроме того, у большинства пациентов диагностируются выраженные костные и почечные осложнения гиперпаратиреоза, а у некоторых определяются симптомы ...
I V Kim, N S Kusnezov, S N Kusnezov
openaire +2 more sources
Severe Hyperparathyroidism Versus Parathyroid Carcinoma : A clinical dilemma
Sultan Qaboos University Medical Journal, 2010 No clinical or laboratory data allow a preoperative diagnosis of parathyroid carcinoma and only occasionally does a definitive finding differentiate an adenoma from a carcinoma.
Mariam Al-Fadhli +3 more
doaj
Parathyroid Double Adenoma Associated with Papillary Carcinoma of Thyroid [PDF]
It has been reported that thyroid disease is common in patients with hyperparathyroidism, and vice versa. Parathyroid adenoma is the most common cause of primary hyperparathyroidism (PHPT).
ایرانپرور, منوچهر +3 more
core
PTHrP treatment of colon cancer cells promotes tumor associated-angiogenesis by the effect of VEGF [PDF]
, 2019 We showed that Parathyroid Hormone-related Peptide (PTHrP) induces proliferation, migration, survival and chemoresistance via MAPKs and PI3K/AKT pathways in colorectal cancer (CRC) cells.
Calvo, Natalia Graciela +4 more
core +1 more source
G Protein‐Coupled Receptor Signaling: Implications and Therapeutic Development Advances in Cancers
MedComm, Volume 6, Issue 10, October 2025.G protein‐coupled receptors (GPCRs) are the dynamic protein family in the human genome. GPCR dysregulation aids in the advancement of cancer through increased migration, survival, and proliferation. Novel treatments that target GPCR signaling include orthosteric ligands, biased receptor mutants, PROTACs, and antibody–drug conjugates.
Inamu Rashid Khan +6 more
wiley +1 more source
Current Problems in Cancer: Case ReportsParathyroid carcinoma is one of the rare causes of primary hyperparathyroidism, comprising less than 1 % of its cases. Diagnosing parathyroid carcinoma typically requires a comprehensive evaluation using clinical, histological, and radiological methods ...
Syeda Sara Tajammul +6 more
doaj +1 more source
Case Reports in Medicine, 2014 Context. Severe hypercalcemia is a life-threatening condition. Atypical parathyroid adenoma and parathyroid carcinomas are uncommon causes which can be difficult to differentiate. Objective.
Ankur Mishra, David Newman
doaj +1 more source
Coexistence of parathyroid adenoma and papillary thyroid carcinoma: Experience of a single center [PDF]
, 2013 Objective: The aim of this study was to describe experienceswith concurrent parathyroid adenoma and papillarythyroid carcinoma.Methods: Eight patients with concurrent parathyroid adenomaand papillary thyroid carcinoma were identifiedbetween 2005 and 2012,
Ebubekir Gündeş +4 more
core +2 more sources
Clinical Endocrinology, Volume 103, Issue 4, Page 587-595, October 2025.ABSTRACT Objective Calcitonin (CT) represents the most important biochemical marker of medullary thyroid cancer (MTC), but has certain limits. Procalcitonin (ProCT) has been recognized as an alternative or additional marker for MTC. The aim of the study is to evaluate prospectively the role of ProCT combined with CT in the identification of MTC ...
Cristina Clausi +13 more
wiley +1 more source